Further processing options
CERIVASTATIN INHIBITS INFLAMMATORY MECHANISMS AND AMELIORATES END-ORGAN DAMAGE VIA INHIBITION OF THE MAP KINASE PATHWAY AND NFkB ACTIVATION : P2.168: P2.168
Saved in:
Journal Title: | Journal of Hypertension |
---|---|
Authors and Corporations: | , , , , , , , , |
In: | Journal of Hypertension, 18, 2000, p. S132 |
Type of Resource: | E-Article |
Language: | English |
published: |
Ovid Technologies (Wolters Kluwer Health)
|
Subjects: |